Justin Walsh analyst JONESTRADING

Currently out of the existing stock ratings of Justin Walsh, 66 are a BUY (85.71%), 11 are a HOLD (14.29%).

Justin Walsh

Work Performance Price Targets & Ratings Chart

Analyst Justin Walsh, currently employed at JONESTRADING, has had 37.91% of price targets met with an average potential upside of 74.74%, reached in 138 days on average.

Justin Walsh has documented 139 price targets and ratings displayed on 25 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on ATAI, ATAI Life Sciences BV at 17-Jul-2026.

Wall Street Analyst Justin Walsh

Analyst best performing recommendations are on MNPR (MONOPAR THERAPEUTICS).
The best stock recommendation documented was for CATX (PERSPECTIVE THERAPEUTICS) on 12/18/2023. The price target of $15 was fulfilled within 113 days with a profit of $12.41 (479.15%), with a performance score of 42.4.

Average potential price target upside

ACHV Achieve Life Sciences ANRO Alto Neuroscience BLRX BioLineRx Ltd CATX Perspective Therapeutics LNTH Lantheus Holdings MNPR Monopar Therapeutics PRAX Praxis Precision Medicines PSTV Plus Therapeutics THTX Theratechnologies TLSI TriSalus Life Sciences VRA Vera Bradley VRAY ViewRay YMAB Y mAbs Therapeutics XAIR Beyond Air ATNM Actinium Pharmaceuticals CKPT Checkpoint Therapeutics CMPX Compass Therapeutics CTSO Cytosorbents Crp ETON Eton Pharmaceuticals HROW Harrow Health PGEN Precigen VOR Vor Biopharma ATAI ATAI Life Sciences BV GTBP GT Biopharma NMTC Neuroone Medical Technologies Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Sep-2024

$13

$6.72 (107.01%)

$13

4 months 26 days ago
(23-Jun-2026)

0/4 (0%)

$7.99 (159.48%)

Buy Since 14-Nov-2024

$12

$5.72 (91.08%)

$12

4 months 27 days ago
(22-Jun-2026)

0/6 (0%)

$6.9 (135.29%)

Buy Since 23-Jun-2021

$11

$11

1 years 11 months 14 days ago
(04-Dec-2024)

0/9 (0%)

$6.47 (142.83%)

Buy Since 16-Apr-2024

$20

$20

2 years 1 months 8 days ago
(10-Oct-2024)

0/3 (0%)

$15.05 (304.04%)

Buy Since 17-Sep-2020

$11

$19

2 years 8 months 13 days ago
(05-Mar-2024)

0/5 (0%)

$6.61 (150.57%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Justin Walsh most bullish on?

Potential upside of $27.41 has been obtained for LNTH (LANTHEUS HOLDINGS)

Which stock is Justin Walsh most reserved on?

Potential downside of -$0 has been obtained for ATAI (ATAI LIFE SCIENCES BV)

What Year was the first public recommendation made by Justin Walsh?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?